Chong Kun Dang Pharmaceutical Corp. (185750) Price & Analysis

― Followers

185750 Stock Chart & Stats

$65600.00

-$1,900.00(-2.81%)

Jul 29, 2026

―

Day’s Range― - ―

52-Week Range$63,000.00 - $98,100.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩889.38B

Enterprise Value$1.26M

Total Cash (Recent Filing)₩285.23B

Total Debt (Recent Filing)₩368.00B

Price to Earnings (P/E)11.3

Beta0.21

Next Earnings

Aug 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)5960.92

Shares Outstanding13,802,780

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio-0.50

Price to Book (P/B)1.09

Price to Sales (P/S)0.65

P/FCF Ratio-14.86

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

185750 FAQ

What was Chong Kun Dang Pharmaceutical Corp.’s price range in the past 12 months?

Chong Kun Dang Pharmaceutical Corp. lowest stock price was $63000.00 and its highest was $98100.00 in the past 12 months.

What is Chong Kun Dang Pharmaceutical Corp.’s market cap?

Chong Kun Dang Pharmaceutical Corp.’s market cap is ₩889.38B.

When is Chong Kun Dang Pharmaceutical Corp.’s upcoming earnings report date?

Chong Kun Dang Pharmaceutical Corp.’s upcoming earnings report date is Aug 18, 2026 which is in 18 days.

How were Chong Kun Dang Pharmaceutical Corp.’s earnings last quarter?

Chong Kun Dang Pharmaceutical Corp. released its earnings results on May 15, 2026. The company reported $973.022 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Chong Kun Dang Pharmaceutical Corp. overvalued?

According to Wall Street analysts Chong Kun Dang Pharmaceutical Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Chong Kun Dang Pharmaceutical Corp. pay dividends?

Chong Kun Dang Pharmaceutical Corp. does not currently pay dividends.

What is Chong Kun Dang Pharmaceutical Corp.’s EPS estimate?

Chong Kun Dang Pharmaceutical Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Chong Kun Dang Pharmaceutical Corp. have?

Chong Kun Dang Pharmaceutical Corp. has 13,802,780 shares outstanding.

What happened to Chong Kun Dang Pharmaceutical Corp.’s price movement after its last earnings report?

Chong Kun Dang Pharmaceutical Corp. reported an EPS of $973.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.932%.

Which hedge fund is a major shareholder of Chong Kun Dang Pharmaceutical Corp.?

Currently, no hedge funds are holding shares in KR:185750

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Chong Kun Dang Pharmaceutical Corp.

Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetics, antiviruses, beta-blockers, anti-hyperlipidemia, and others. The company was founded on May 7, 1941 and is headquartered in Seoul, South Korea.